Issue link: https://nebusinessmedia.uberflip.com/i/1523471
wbjournal.com | Book of Lists 2024 | Worcester Business Journal 13 F O C U S B A N K I N G & F I N A N C E F O C U S Can we create a CUSTOM magazine for you? Whether it's the celebration of a major anniversary or the opening of a new headquarters, Worcester Business Journal's Custom Publishing Division can help you create a custom magazine for your business. Our division's top flight team of writers and designers can help you tell your story – and make your business look great! Based on our unique publishing model, it's surprisingly affordable. Call WBJ Custom Corporate Project Director Christine Juetten at 508-755-8004 ext. 270. Worcester Business Journal WBJ Custom Publishing Division Building on the past; creating the future An advertising supplement to the Worcester Business Journal Harding Green N E W I N V E S T M E N T I N W O R C E S T E R ' S C A N A L D I S T R I C T Notable venture capital deals Ranked by funding amount, then transaction date Company Industry/ products and services Funding amount/ type/ transaction date Select investors Head of company 1 Sionna Therapeutics Natick sionnatx.com Life sciences Cystic fibrosis treatments $182,000,000 Series C March 2024 Viking Global Investors, Q Healthcare Holdings, Perceptive Advisors, Cystic Fibrosis Foundation Mike Cloonan president & CEO 2 Ascend Elements Westborough ascendelements.com Manufacturing Sustainable materials for batteries $162,000,000 Series D February 2024 Pario Ventures, Just Climate, Irongrey, Clearvision Ventures Mike O'Kronley CEO 3 Solid Biosciences Marlborough solidbio.com Life sciences Duchenne muscular dystrophy treatments $109,000,000 Post-IPO equity January 2024 Vestal Point Capital, RA Capital Management, Perceptive Advisors, Janus Henderson Advisors, Invus Bo Cumbo president & CEO 4 Alzheon Framingham alzheon.com Life sciences Alzheimer's disease treatments $100,000,000 Series E June 2024 Alerce Medical Technology Partners Martin Toler CEO 5 Aspen Aerogels Northborough aerogel.com Energy Performance and safety of electric vehicles $75,000,000 Post-IPO equity December 2023 Hood River Capital Management Donald Young CEO 6 AMSC Ayer amsc.com Energy Electric power infrastructure $60,750,000 Post-IPO equity January 2024 Baird Capital Daniel McGahn CEO 7 Reprieve Cardiovascular Milford reprievecardio.com Life sciences Fluid removal for patients with heart failure $42,000,000 Series A February 2024 Sante Ventures, Lightstone Ventures, Genesis Capital, Deerfield Management, Aboretum Ventures Mark Pacyna CEO 8 Variantyx Framingham variantyx.com Life sciences Treatments for rare genetic disorders $36,000,000 Series D April 2024 Pitango VC, Peregrine Ventures, New Era Capital Partners, Bosch Ventures Haim Neerman CEO 9 Stellaromics Natick stellaromics.com Life sciences 3D in situ multi-omic analysis technology $25,000,000 Series A November 2023 Plaisance Capital Management Todd Dickinson CEO 10 Jetcool Technologies Littleton Manufacturing Cooling systems for electronics $17,000,000 Series A October 2023 Schooner Capital, Raptor Group, In-Q-Tel, Bosch Ventures Bernie Malouin CEO 11 MeaCor Ayer meacor.com Life sciences Minimally invasive heart valve repair solutions $15,000,000 Series A May 2024 Undisclosed Toufic Azar CEO & CTO Source: Crunchbase. Notes: Deals completed from July 1, 2023 through June 17, 2024 were considered for this list. N/A=not available. -Compiled by: Stephanie R. Meagher, research@nebusinessmedia.com